Report: Developer of ReWalk, Argo To Raise Up To $50M On Nasdaq

July 1, 2014 | The developer of the ReWalk exoskeleton, Argo Medical Technologies, will attempt to raise $40-50 million on Nasdaq at a company value of $250-300 million, according to a “Globes” report. Earlier this week, the ReWalk exoskeleton, designed to help paraplegics and quadriplegics usually confined to wheelchairs walk again, was approved by the Food & Drug Administration (FDA) in the United States for use at home and in the community. Argo Medical Technologies was founded by Dr. Amit Goffer in 2001 and quickly grew from a small startup based in Israel to an international company with offices in the US, Germany and Israel.